Unplanned Surgical Incisions in Bone and Soft Tissue Tumor Biopsy: Are we up to the mark?

Authors

  • Farman Ullah Fellow Musculoskeletal Oncology, Rehman Medical Institute, Peshawar Pakistan
  • Syed Asif Shah Associate Professor Plastic Sugary, Hayatabad Medical Complex, Peshawar
  • Zeeshan Khan Consultant Orthopaedic surgeon Rehman Medical Institute Hayatabad Peshawar.

Abstract

Objective: To determine the frequency of inappropriately placed biopsy incision in patients with bone and soft tissue tumors.

Methods: This retrospective cross sectional study was conducted in Orthopaedic and Oncology unit Rehman Medical Institute. The records of all the patients with bone and soft tissue tumors presented during time period extending from 23rd May 2017 to 23rd June 2022 were reviewed. Appropriateness of the surgical margins and surgical scars were assessed after complete staging studies. During subsequent surgery, if required, the need for complex reconstructive procedures in the form of local or free flaps or skin grafting was assessed along with ablative surgery due to the wrongly placed surgical incisions.

Results: The records of 451 patients were studied out of which 184(40.79%) patients had biopsies performed in the author's institution. Of the remaining patients 77(28.83%) had wrong or inappropriately based surgical incisions with most of those were in soft tissue tumor cases (75.32%). Few (10.38%, n=8) of the inappropriately based incision cases had to undergo amputation while the rest had their limb salvaged.

Conclusion: The frequency of inappropriately placed biopsy incision in patients with bone and soft tissue tumors was high. We are not up to the mark. We recommend further training for musculoskeletal (MSK) oncology cases performed only in referral units to optimize outcome.

References

Lahat G, Lazar A, Lev D. Sarcoma epidemiology and etiology: potential environmental and genetic factors. Surgical Clinics of North America. 2008;88(3):451-81.

Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA: a cancer journal for clinicians. 2015;65(1):5-29.

Hui JY. Epidemiology and etiology of sarcomas. SurgClin North Am. 2016;96(5):901-14.

Welker JA, Henshaw RM, Jelinek J, Shmookler BM, Malawer MM. The percutaneous needle biopsy is safe and recommended in the diagnosis of musculoskeletal masses: outcomes analysis of 155 patients at a sarcoma referral center. Cancer. 2000;89(12):2677-86.

Khan Z. Diagnostic Accuracy of Core Needle Biopsy in Bone Tumors. Results of 100 Consecutive Cases from a Sarcoma Unit in Pakistan. EC Orthopaedics. 2020; 11:01-6.

Yang YJ, Damron TA. Comparison of needle core biopsy and fine-needle aspiration for diagnostic accuracy in musculoskeletal lesions. Archives of pathology & laboratory medicine. 2004;128(7):759-64.

Avedian RS. Principles of musculoskeletal biopsy. Orthopaedic Oncology. 2014:1-7.

Shives TC. Biopsy of soft-tissue tumors. Clinical orthopaedics and related research. 1993(289):32-5.

Gerrand CH, Rankin K. The hazards of biopsy in patients with malignant primary bone and soft-tissue tumors. Classic Papers in Orthopaedics: Springer; 2014. p. 491-3.

Siebenrock K, Hertel R, Ganz R. Unexpected resection of soft-tissue sarcoma. Archives of orthopaedic and trauma surgery. 2000;120(1):65-9.

Yao L, Nelson SD, Seeger LL, Eckardt JJ, Eilber FR. Primary musculoskeletal neoplasms: effectiveness of core-needle biopsy. Radiology. 1999;212(3):682-6.

Koulaxouzidis G, Schwarzkopf E, Bannasch H, Stark GB. Is revisional surgery mandatory when an unexpected sarcoma diagnosis is made following primary surgery? World Journal of Surgical Oncology. 2015;13(1):1-10.

Charoenlap C, Imanishi J, Tanaka T, Slavin J, Ngan SY, Chander S, et al. Outcomes of unplanned sarcoma excision: impact of residual disease. Cancer medicine. 2016;5(6):980-8.

Siegel HJ, Brown O, Lopez-Ben R, Siegal GP. Unplanned surgical excision of extremity soft tissue sarcomas: patient profile and referral patterns. Journal of surgical orthopaedic advances. 2009;18(2):93-8.

Simon MA, Bierman JS. Biopsy of Bone and Soft Tissue Lesions. J. Bone Joint Surg. 1993; (75A) ICL: 616-21.

Giuliano AE, Eilber FR. The rationale for planned reoperation after unplanned total excision of soft-tissue sarcomas. J ClinOncol 1985; 3:1344–8.

Kawaguchi N, Ahmed AR, Matsumoto S, Manabe J, Matsushita Y. The concept of curative margin in surgery for bone and soft tissue sarcoma. ClinOrthopRelat Res 2004; 419:165–72.

Chandrasekar CR, Wafa H, Grimer RJ, Carter SR, Tikkman RM, Abudu A. The effect of an unplanned excision of a soft-tissue sarcoma on prognosis. J Bone Joint Surg Br. 2008; 90:203e208.

Mankin HJ, Simon MA. The hazards of biopsy, revisited. J. Bone Joint Surg. 1996. (78A): 656–3.

Chen CF, Wu PK, Chen WM. Unplanned resection of soft tissue sarcoma. Formosan Journal of Surgery. 2015 Aug 1;48(4):117-20.

Mankin HJ, Mankin CJ, Simon MA. The hazards of the biopsy, revisited. Members of the Musculoskeletal Tumor Society. J Bone Joint Surg Am. 1996; 78:656e663.

Hoshi M, Ieguchi M, Takami M, Aono M, Taguchi S, Kuroda T, Takaoka K. Clinical problems after initial unplanned resection of sarcoma. Japanese Journal of Clinical Oncology. 2008 Oct 1;38(10):701-9.

Downloads

Published

2022-12-16

How to Cite

Ullah, F., Syed Asif Shah, & Zeeshan Khan. (2022). Unplanned Surgical Incisions in Bone and Soft Tissue Tumor Biopsy: Are we up to the mark?. Journal of Pakistan Orthopaedic Association, 34(04), 136–140. Retrieved from https://jpoa.org.pk/index.php/upload/article/view/683